Skip to content
Low Dose GLP-1Providers

Provider review

MadeMed review

Oral routes for both molecules, priced flat — which is exactly what a microdoser overpays.

One figure at every dose removes titration surprises and charges a quarter dose like a full one.

Price as published

Semaglutide $239/mo quarterly (from $199 on six months) · tirzepatide $399/mo quarterly (from $369 on six) — the SAME price at every dose

Visit MadeMed

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

The verdict

MadeMed publishes its price at every single dose, semaglutide and tirzepatide alike, and offers oral routes for both — which is what earns it a place on this board at all. The flat structure cuts precisely two ways, and on this site the second one dominates: it removes any surprise as you titrate up, and it means someone deliberately staying at a quarter dose pays exactly what someone at the full dose pays. It is verified, ships overnight with supplies included, and refunds all but a visit fee if you are not prescribed. It is also available in fewer states than most of this board.

The trade-off we would want you to read first

⚠ Flat pricing means a low-dose patient pays the full-dose rate — the least economical structure on this board for anyone staying small

Who it suits, and who it does not

A good fit if

  • You want an oral route for tirzepatide or semaglutide with a published price
  • You expect to titrate upward and want no price change when you do
  • You want supplies and overnight shipping included rather than added

Look elsewhere if

  • You intend to stay at a small dose — flat pricing is the least economical structure for that
  • You want the cheapest tirzepatide on this board
  • You live in one of the states it does not serve

How the programme works

LegitScript-verified compounded telehealth that publishes its price at every single dose — semaglutide 0.25mg through 2.4mg, tirzepatide 2.5mg through 15mg, one figure throughout. Oral semaglutide and oral tirzepatide are offered alongside the injections, which is what earns it a place here. But the flat structure cuts both ways for this audience: it removes any surprise as you titrate up, and it means someone deliberately staying at a quarter dose pays the same as someone at the full one.

At a glance

Pricing structure
Flat at every dose
Consult
Included in the price
Compounding
Not publicly identified
Labs
Not required
Dietitian support
Not included

Strengths

  • Oral semaglutide and oral tirzepatide offered alongside the injections
  • One price published at every dose, so there is no surprise if you do titrate upward
  • LegitScript verified, with board-certified physician review and a refund minus a $39 visit fee if you are not prescribed
  • Free overnight shipping with injection supplies included

The other trade-offs

  • Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
  • The most expensive tirzepatide here at $399/mo quarterly
  • Available in 40 states rather than nationwide

Before you buy

Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

Where this sits on the board

MadeMed is one of 24 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

Funding & disclosures

  • A number of links are affiliate or referral links.
  • Begin treatment through one and we may earn a commission via the Katalys network — at no added cost to you.
  • What we write about a provider is the same either way — unflattering findings about one that pays us stay in.
  • Full detail: disclosure page.